CTRI/2021/01/030802尚未招募未知
Sacubitril/valsartan in heart failure with reduced ejection fraction (HFrEF) patients: a real-world study in India
ovartis Healthcare Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients >= 18 years with a diagnosis of HFrEF as mentioned in database or heart failure with a recording of LVEF <40% at or before the index date.
- •A prescription of sacubitril/valsartan
排除标准
- •Diagnosis of HF specified as preserved/mid-range ejection fraction
研究者
相似试验
进行中（未招募）
1 期
PRAISE-MR trialHeart failure with preserved ejection fraction Secundary mitral valve regurgitationCTIS2023-506634-70-00Ziekenhuis Oost Limburg110
招募中
不适用
Sacubitril/Valsartan Versus Valsartan in Heart Failure With Improved Ejection FractionHeart Failure, SystolicNCT04803175Samsung Medical Center100
招募中
3 期
The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection FractionHeart Failure With Moderately Reduced Ejection FractionNCT05508035John Paul II Hospital, Krakow488
已完成
4 期
Efficacy of Sacubitril valsartan for chronic heart failure: A prospective observation studychronic heart failure during ACE-i or ARB treatmentJPRN-UMIN000041650Sekino Hospital120
已完成
4 期
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve RegurgitationHeart Failure With Preserved Ejection FractionFunctional Mitral RegurgitationNCT05991284Ziekenhuis Oost-Limburg84